IOVANCE BIOTHERAPEUTICS, INC.
Ticker: 1425205
values in millions
Revenue & Profit Trend
in millionsRevenueExpenditureNet Profit
Margin Trend
percentageOPM %NPM %
| Period | Q1 FY2026 | Q3 FY2025 | Q2 FY2025 | Q1 FY2025 | Q3 FY2024 | Q2 FY2024 | Q1 FY2024 | Q3 FY2023 |
|---|---|---|---|---|---|---|---|---|
| INCOME | ||||||||
| Revenue | 71.43+5.9% | 67.46+12.5% | 59.95+21.6% | 49.32-15.8% | 58.56+88.2% | 31.11+4220.8% | 0.72+53.2% | 0.47 |
| Total Income | 71.43+5.9% | 67.46+12.5% | 59.95+21.6% | 49.32-15.8% | 58.56+88.2% | 31.11+4220.8% | 0.72+53.2% | 0.47 |
| EXPENSES | ||||||||
| Expenditure | 152.47-6.1% | 162.36-6.5% | 173.73+1.9% | 170.55+15.5% | 147.62+11.0% | 133.02+12.3% | 118.44-0.3% | 118.83 |
| Tax | -0.67+72.2% | -2.41-221.1% | 1.99+208.2% | -1.84-21.1% | -1.52-4.1% | -1.46-3.5% | -1.41-13.7% | -1.24 |
| PROFIT | ||||||||
| PBT | -79.71+14.9% | -93.66+14.6% | -109.67+7.1% | -118.00-38.7% | -85.06+13.7% | -98.56+13.8% | -114.38+0.5% | -115.00 |
| Net Profit | -79.05+13.4% | -91.25+18.3% | -111.66+3.9% | -116.16-39.0% | -83.54+14.0% | -97.10+14.1% | -112.98+0.7% | -113.76 |
| KEY METRICS | ||||||||
| OPM % | -100.00% | -100.00% | -100.00% | -100.00% | -100.00% | -100.00% | -100.00% | -100.00% |
| NPM % | -100.00% | -100.00% | -100.00% | -100.00% | -100.00% | -100.00% | -100.00% | -100.00% |
| EPS | -0.19+24.0% | -0.25+24.2% | -0.33+8.3% | -0.36-28.6% | -0.28+17.6% | -0.34+19.0% | -0.42+8.7% | -0.46 |
Corporate Events
Board MeetingIOVA
202610Jun
Board Meeting
Annual Meeting of Stockholders to elect directors, approve e…
SEC Filing ↗